PAK4 and glioblastoma: In addition, it has been shown that deletion of the PAK4 gene in endothelial cells remodels the vascular microenvironment leading to increased T-cell infiltration and improved responses to chimeric antigen receptor (CAR)-T immunotherapy in glioblastoma (26).